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in KCNQ1 (representing 10% of allKCNQ1 mutations). In addition, 4 nonsense mu-
tations were found in KCNH2, whereas only 1 in KCNQ1 and none in SCN5A.
Conclusions: The present study shows that average QTc, Schwartz score,episodes of
syncopeare associated with a higher detection rate of mutations in LQTS among
Chinese patients. In addition, our study indicates that the majority mutations harbored
by LQTS patients are on LQT1-3 causing genes and LQT2 is the most common
subtype in Chinese patients. The present study also expands the spectrum of LQTS-
causing mutations in Chinese.
For Chinese Channelopathy Register Investigators
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Renal denervation suppresses atrial ﬁbrillation in a model of renal impairment
Liang Zhuo, Zhao-Liang Shan, Xiang-Min Shi, Hong-Yang Guo, Kun Lin,
Jian-Ping Guo, Yu-Tang Wang
Chinese PLA General Hospital
Objectives: A close association exists between chronic kidney disease (CKD) and
atrial ﬁbrillation (AF) occurrence. Activation and overactivity of sympathetic nervous
system (SNS) may be one of the pathogenic mechanisms responsible for the devel-
opment of AF associated with renal impairment (RI). Renal denervation (RDN)
decreases sympathetic renal afferent nerve activity, leading to decreased central
sympathetic drive.The main objective of the study was to explore the effects of SNS
and RDN on AF inducibility in anesthetized beagles with RI.
Methods: Unilateral RI was induced in beagles by embolization of small branches of
the renal artery in the left kidney using gelatin sponge granules in RI (n¼6) and
RI+RDN group (n¼6). The control group (n¼6) underwent the same procedure,
except for embolization. Then animals in RI+RDN group underwent radiofrequency
ablation of the renal sympathetic nerve. Cardiac electrophysiological parameters,
blood pressure (BP), AF inducibility, plasma norepinephrine, renin and aldosterone
were measured at baseline and after 2 weeks. Levels of angiotensin II, aldosterone,
transforming growth factor-b (TGF-b) and ﬁbrosis in atrial tissue were measured after
2 weeks.
Results: We observed 5 main ﬁndings. (1) Embolization of small branches of the
renal artery in the left kidney led to ischemic RI with mild renal insufﬁciency. (2)
Heart rate and BP were elevated by RI, which were reversed by RDN. (3) Atrial
effective refractory period was shortened and AF inducibility was increased by RI,
which were reversed by RDN. (4) Antegrade Wenckebach point was shortened and
ventricular rate during AF was increased by RI, which were reversed by RDN. (5)
Plasma norepinephrine level was elevated by RI, levels of renin and aldosterone in
plasma, angiotensin II aldosterone, TGF-b and ﬁbrosis in atrial tissue were elevated by
RI, which were reversed by RDN.
Conclusions: RDN signiﬁcantly reduced AF inducibility, reversed the atrial electro-
physiological changes and inhibited ﬁbrotic pathway in a model of RI by combined
reduction of sympathetic drive and renin-angiotensin-aldosterone system activity.
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The role of PDE5 in resveratrol-induced cardioprotection against ischemia/
reperfusion injury
X. I. Jinkun, Zhelong Xu
Department of Physiology and Pathophysiology, Tianjin Medical University
Objectives: Resveratrol has been established to be cardioprotective and our previous
study demonstrated that resveratrol prevents cardiac reperfusion injury by targeting
the mitochondrial permeability transition pore (mPTP) through inactivation of
GSK-3b via the cGMP/PKG signaling pathway. Nevertheless, the exact mechanism
by which resveratrol activates the cGMP/PKG pathway remains unclear. The intra-
cellular cGMP level is regulated by both guanylyl cyclase that promotes the synthesis
of cGMP using NO and phosphodiesterase (PDE) that induces the hydrolysis of
cGMP. The purpose of this study was to explore the molecular mechanism by which
resveratrol increases intracellular cGMP leading cardioprotection against reperfusion
injury, focusing on the roles of NO and PDE5.
Methods: Rat cardiomyocytes were isolated enzymatically. Fluorescence dye
4-amino-5-methylamino-2’, 7’-diﬂuoroﬂuorescein (DAF-FM) was used to image NO.
Fluorescence images were obtained with confocal microscopy. Isolated rat hearts were
subjected to 30 min regional ischemia followed by 2 h of reperfusion. Myocardial
samples were collected from the risk zone for PDE5 activity, cGMP levels, and
western blot analysis. Infarct size was measured by TTC staining. Mitochondrial
swelling was measured spectrophotometrically as a decrease in absorbance at 520 nm
(A520).
Results: Cardiomyocytes treated with resveratrol for 10 min did not show a signiﬁcant
increase in DAF-FM ﬂuorescence intensity, indicating that resveratrol does not pro-
duce NO. In contrast, resveratrol signiﬁcantly reduced PDE5 activity and increased
cGMP levels at reperfusion in the heart, indicating that the cardioprotective effect of
resveratrol is not mediated by guanylyl cyclase but is dependent on PDE5. The non-
selective PDE inhibitor 3-isobutyl-1-methylxanthine (IBMX) could mimic the car-
dioprotective effect of resveratrol by reducing infarct size through modulation of the
mPTP opening. In addition, resveratrol enhanced the phosphorylation of VASP and
GSK-3b, an effect that was partially blocked by PKG inhibitor KT5823.
Conclusions: Inhibition of PDE5 leading to the increase in intracellular cGMP
accounts for the cardioprotective effect of resveratrol on reperfusion injury through
prevention of the mPTP opening via the cGMP/PKG/GSK-3b signal pathway.C26 JACC Vol 64/16/Suppl C j OctobGW25-e5194
A protective role of SIRT3 in endothelial function under metabolic stress
Yang Lu, Gao Feng
Fourth Military Medical University
Objectives: Recent evidence has shown that loss of SIRT3 contributes to the
development of the metabolic syndrome but the role of SIRT3 in endothelium
dysfunction under metabolic stress has not been identiﬁed.
Methods: Male SIRT3 KO and age-matched wide type mice were fed with standard
chow diet or high fat diet (HFD) for 24 weeks. The vasoactive responses to phen-
ylephrine, sodium nitroprusside and acetylcholine and ROS production in isolated
thoracic aortic segments were determined.
Results: Phenylephrine, sodium nitroprusside, and acetylcholine evoked similar
vascular responses in SIRT3 KO and wild type mice fed with standard chow diet.
However, compared with the wild type fed with HFD, endothelium-dependent
relaxation to acetylcholine was impaired in SIRT3 KO mice fed with HFD.
Furthermore, SIRT3 KO mice fed with HFD displayed decreased NO bioavailability
and increased mitochondrial superoxide formation compared with the wild control fed
with HFD. In human endothelial cells, SIRT3 knockdown exacerbated mitochondrial
ROS production while SIRT3 overexpression protected endothelial function against
palmitate treatment.
Conclusions: Our data have shown that SIRT3 deﬁciency increases mitochondrial
ROS production and exacerbates endothelium dysfunction in mice fed with high-fat
diet, indicating a protective role in endothelial homeostasis under metabolic stress.
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Rosuvastatin Attenuates Lps-Induced Adhesion Molecules Expression in Human
Umbilical Vein Endothelial Cells
Hao Baoshun1, Liu Xuelian2, Liu Yong1, Yu Shujie1, Liu Dinghui1, Qian Xiaoxian1
1Department of Cardiology, The Third Afﬁliated Hospital of Sun Yat-sen University,
2Department of Radiology, The Third Afﬁliated Hospital of Sun Yat-sen University
Objectives: Stable adhesion and transendothelial migration of leukocytes into the
vascular wall play an important role in atherogenesis. Cell adhesion molecules such as
intracellular cell adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1
(VCAM-1) mainly mediates in this process. We investigated the effect of rosuvastatin,
an inhibitor of HMG-CoA reductase administered to reduce plasma levels of
LDLcholesterol, on the expression of VCAM-1 and ICAM-1 by human umbilical vein
endothelial cells (HUVEC) stimulated with lipopolysaccharide (LPS).
Methods: The HUVECs were primary cultured. HUVECs from the second to fourth
generations were stimulated with different concentrations of LPS and the model of cell
injury was set up. Then the HUVECs were pretreated with rosuvastatin in different
concentration for 2 hours before LPS is added. The expression of VCAM-1 mRNA
and ICAM-1 mRNA was evaluated by real time-PCR. The content of VCAM-1
protein and ICAM-1 protein was detected with western blot. mevalonate (MEV) was
added to evaluate whether the effect of rosuvastatin on expression of VCAM-1 and
ICAM-1 protein can be blocked.
Results: We found the expression of cell adhesion molecules to be signiﬁcantly
inhibited by the rosuvastatin in a time and concentration-dependent manner and to a
greater extent in the case of VCAM-1 as compared with ICAM-1. The content of
VCAM-1 protein and mRNA, ICAM-1 protein and mRNA signiﬁcantly decreased
when pretreated with certain concentration of rosuvastatin (P<0$05). The effects of
rosuvastatin on VCAM-1 and ICAM-1 protein can’t be blocked by mevalonate.
Rosuvastatin inhibited LPS-induced activation of nuclear factorkB (NF-kB).
Conclusions: The ﬁndings suggest that the beneﬁts of rosuvastatin in vascular disease
may include the inhibition of expression of VCAM-1 and ICAM-1 through effects on
NF-kB, and the effect is independent on its lipid-lowering effect.
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Lycopene protects endoplasmic reticulum stress induced apoptosis against
neonatal mouse cardiomyocytes hypoxia/reoxygenation injury
Jiqian Xu1,2, Houxiang Hu1, Bin Chen2, Zhou Zhou3, Lei Xu1, Shuang Zhang1,
Zhengping Yu3
1Department of Cardiology, North Sichuan Medical College First Afﬁliated Hospital,
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Objectives: Endoplasmic reticulum (ER) stress induced apoptosis has been implicated
as a critical cause in the pathogenesis of myocardial ischemia reperfusion (I/R) injury.
Our previous studies demonstrated that lycopene exhibits great pharmacological
potential in protecting against the I/R-injury, but whether its effect is mediated through
attenuation of ER stress-induced apoptosis remains unclear. The aim of this study was
to investigate the effect of lycopene on hypoxia/reoxgenation (H/R) induced ER stress
in primary cultured neonatal mouse cardiomyocytes.
Methods: Primary cardiomyocytes were isolated from neonatal C57BL/6 mice and
divided into four groups: control, lycopene, H/R, lycopene + H/R. The cultured
cardiomyocytes underwent 4h of hypoxia followed by 6h of reoxgenation to achieve
H/R model. Cardiomyocytes were pretreated with lycopene (5 mM) prior to H/R
treatment in lycopene + H/R. Cell viability was assessed using CCK-8 assay in eacher 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
group. Annexin V -FITC/PI assay was used to evaluate cardiomyocytes apoptosis in
the different treatment groups. The expression of GRP78, a widely used marker of
endoplasmic reticulum stress, was measured via western blot. The expression of
ER-related apoptotic maker of CHOP/GADD153 and caspase-12 was measured by
real-time PCR.
Results: Our results demonstrate that the cell viability signiﬁcantly decreased to
66.304.84% of the control levels following H/R, the cell viability markedly
improved in lycopene + H/R (P<0.01). The results from ﬂow cytometer with Annexin
V and PI double-staining illustrated that after exposure to H/R, apoptotic percentage
signiﬁcantly increased to 26.422.71% (P<0.01), while that of control and lycopene
group were 4.961.51% and 4.691.42%, respectively. In contrast, lycopene + H/R
markedly prevented the H/R-induced apoptosis (16.382.12%, P<0.01). Compared
to control and lycopene, the expression of GRP78 protein increased more than two-
fold in H/R treatment (P<0.01), while the expression of GRP78 protein only increased
to 1.46-fold in lycopene + H/R (P<0.01). In addition, H/R treatment evoked a sig-
niﬁcant increase in GADD153/CHOP mRNA compared to control groups (P<0.01).
However, the GADD153/CHOP mRNA expression was markedly down-regulated to
1.68-fold of control levels with lycopene pretreatment (P<0.01). Furthermore, the
caspase-12 mRNA expression was also signiﬁcantly increased in H/R treatment (1.82
folds of control group, P<0.05). However, pretreatment with lycopene efﬁciently
reduced caspase-12 mRNA expression caused by H/R treatment.
Conclusions: These ﬁndings reveal that lycopene protects against H/R injury by
attenuation of ER stress and ER stress induced apoptosis in primary cultured neonatal
mouse cardiomyocytes; the protective effect of lycopene on cardiomyocytes high-
lights the therapeutic potential of plant-derived antioxidants against I/R-injury.
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Elevated circulating BMP7 reﬂects dysfunction of pulmonary vasculature in
PAH patients
Liu Dong, Yang Yi, Sun Zhichao, Cheng Chunyan, Liu Jinming
Department of Cardio-Pulmonary Circulation, Shanghai Pulmonary Hospital, Tongji
University, School of Medicine, Shanghai, China
Objectives: This study aimed to show whether circulating BMPs levels are associated
with phenotype and increased risk of mortality in PAH patients.
Methods: Circulating BMPs were measured by ELISA in plasma samples from 10
patients with HPAH and 16 corresponding unaffected relatives with BMPR2 muta-
tions. We also explored the role of BMPs in HPAH (n¼43), unrelated IPAH (n¼113)
and normal controls (n¼51).
Results: Circulating BMP7 concentrations but BMP2 and BMP4 were greatly
increased in the 10 HPAH patients compared with their unaffected relatives. Receiver
operating characteristic (ROC) curves indicated that a BMP7 concentration of 13.9
pg/ml could discriminate unaffected mutation carriers from affected mutation carriers
with 70.0% sensitivity and 93.8% speciﬁcity. HPAH patients had signiﬁcantly higher
BMP7 concentrations than IPAH patients and controls (20.1 (2.8-95.5) vs. 6.5
(0.6-41.3) and 2.5 (0.1-31.8) pg/ml, respectively; P <0.001). Elevated plasma BMP7
concentrations were associated with a higher risk of mortality after adjustment for age,
sex, 6-minute walk distance, mean pulmonary arterial pressure, pulmonary vascular
resistance, and cardiac output (HR¼2.674, 95% CI 1.152-6.211; P ¼0.022).
Conclusions: Elevated circulating BMP7 may reﬂect disfunction of pulmonary
vasculature and serve as a speciﬁc biomarker of disease progress in patients with PAH.
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Interaction of HSF1 and Smad3 inhibits cardiac ﬁbrosis and maladaptive
hypertrophy induced by pressure overload
Zhou Ning1, Yong Ye2, Lin Qiu1, Xingxu Wang2, Jian Wu2, Yunzeng Zou2,
Daowen Wang1
1Department of internal medicine and Hypertension Institute, Tongji Hospital, Tongji
Medical College, Huazhong University of Science and Technology, 2Shanghai
Institute of Cardiovascular Diseases, Zhongshan Hospital and Institutes of Biological
Science, Fudan University
Objectives: Heat shock transcription factor 1 (HSF1) plays an important role in the
pressure overload-induced cardiac hypertrophy and ﬁbrosis. However, the mechanism
remains undetermined. The purpose of the present study is to identify the effect of
HSF1 on cardiac ﬁbrosis and maladaptive hypertrophy led by pressure overload and
the underlying mechanisms.
Methods: Expression of P-HSF1 was detected by Western-Blot in human failing heart
samples and control samples collected from the left ventricles of dilated cardiomy-
opathy patients undergoing heart transplants and normal heart donors of trafﬁc acci-
dent victims, respectively. Wild type, HSF1 TG and HSF1-/- mice were imposed with
transverse aortic constriction (TAC) or sham operation for 4 weeks and then subjected
to echocardiography and invasive hemodynamic measurement. Myocardial ﬁbrosis
area (MFA) and perivascular ﬁbrosis area (PVF) were calculated through pathological
analysis. Neonatal mouse cardiomyocytes were cultured and mechanically stretched
after treatment with KNK437 (speciﬁc inhibitors of HSF1) and SIS3 (speciﬁc in-
hibitors of Smad3). Total RNA was prepared from heart tissues of human hearts, mice
or cultured neonatal cardiomyocytes and then used for the realtime-PCR. Total protein
and nuclear protein were extracted for the co-immunoprecipitation investigating the
binding of HSF1 and Smad3.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BResults: Transverse aortic constriction (TAC) for 4 weeks induced severer cardiac
chamber dilation, dysfunction, interstitial and perivascular ﬁbrosis as well as the
reprogramming of fetal genes and over-expression of proﬁbrotic genes in HSF1-/- mice
than in both HSF1 transgenic (TG) and wild type (WT) mice. Furthermore, absence of
HSF1 enhanced activation of Smad3. In contrast, over-expression of HSF1 dramati-
cally inhibited TAC induced-activation of TGF-b and its downstream signaling. In
vitro, mechanical stretch induced reprogramming of fetal genes and enhanced
expression of proﬁbrotic genes and activation of HSF1 (P-HSF1), which were all
facilitated by KNK437 (HSF1 inhibitor) but restrained by S1S3 (Smad3 inhibitor).
The phosphorylation of Smad3 was more signiﬁcant in HSF1-/- mice than those in
HSF1 TG mice after 4 weeks’ TAC. Physical binding of HSF1 and Smad3 was
remarkable in WT mice at 2nd week but less at 4th week after TAC, which was
increasingly raised in HSF1 TG mice after TAC. Mechanical stretch also increased
binding of HSF1 to Smad3 in cardiomyocytes, which can be blocked by either
KNK437 or SIS3.
Conclusions: The interaction of HSF1 and Smad3 restrains the phosphorylation of
Smad3 and then attenuates the TGFb/Smad3 pathway mediated-cardiac ﬁbrosis as
well as cardiac maladaptive hypertrophy led by pressure overload.
GW25-e5207
Tachycardia pacing induces myocardial neovascularization and mobilizes
circulating endothelial progenitor cells partly via SDF-1 pathway in canine
M. A. I. Jingting, YangXin Chen, Qiong Qiu, WoLiang Yuan, JingFeng Wang
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Objectives: To determine the status of neovascularization in non-ischemic cardio-
myopathy induced by chronic rapid ventricular pacing.
Methods: Heart failure was induced by chronic rapid right ventricular pacing at
200 beats/min respectively for 3 weeks and 6 weeks in 12 dogs. Sham-operation was
performed in another 6 dogs as control. Pan-microvessel density (MVD) was assessed
by CD31 and neovascularization density was assessed by CD105.
Results: Three-week tachycardia pacing could induce mild/moderate heart failure and
6-week pacing could induce severe heart failure. Mean CD31-MVD and CD105-
MVD were signiﬁcantly increased after 3-week pacing. However, CD105-MVD was
signiﬁcantly decreased by 80% in 6-week pacing group compared with 3-week pacing
group, whereas CD31-MVD was only decreased slightly (10%; P<0.05). Myocardial
proangiogenic factors stromal cell-derived factor 1 (SDF-1), hypoxia-inducible factors
1a (HIF-1a, a transcription factor which could regulate SDF-1 expression), serum
SDF-1 levels and circulating EPCs mobilization greatly elevated after 3 weeks pacing
but nearly returned to baseline level after 6 weeks pacing, which were in accordance
with the changes of neovascularization levels assessed by CD105. Angiogenesis and
migrating ability of EPCs were enhanced after stimulation of SDF-1, which could be
abolished by pretreatment with SDF-1 receptor antagonist AMD3100. In addition,
angiogenesis and migrating functions of EPCs were signiﬁcantly enhanced by the
serum from 3-week pacing dogs, but had much weaker response to the serum from
6-week pacing dogs.
Conclusions: Tachycardia pacing induced non-ischemic heart failure, promoted
myocardial neovascularization and mobilized circulating EPCs, which might be
mediated partly through SDF-1 pathway.
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BS-KS tablet improves LPA-stimulated endothelial hyperpermeability via
RhoA/ROCK pathway
L. I. Nannan1, GuangYin Zhang1, AiQin Zhong2, AiDi Wang2, LiJun Tian2,
YuanYuan Xu2, JunPing Zhang1
1The First Afﬁliated Hospital of Tianjin,University of TCM, Tianjin, China,
2Tianjin,University of Traditional Chinese Medicine, Tianjin, China
Objectives: Endothelial hyperpermeability is a signiﬁcant problem in many cardio-
vascular disorders, including vascular inﬂammation, ischemia-reperfusion injury,
thrombosis and atherosclerosis. BuShen-KangShuai (BS-KS) tablet, traditional
Chinese medicines, has been used for many years in China to treat cardiovascular
disease. Our previous experiments have revealed that BS-KS could anti-lipid perox-
idation injury, protect endothelial cell funtion, stabilize Atherosclerotic plaque, and
prevent the development of Atherosclerotic. While the mechanisms remain elusive.
This study examined whether BS-KS exerted anti-hyperpermeability effect in
EA.hy296 cells through the RhoA/ROCK pathway.
Methods: Transwell chamber model was used to study the permeability changes of
endothelial cells and it was quantiﬁed by assessing leakage of FITC-dextran. FITC-
Phalloidin immunoﬂuorescence staining was employed to observe morphological
changes in the distribution of F-actin. And the determination of expression of proteins
associated RhoA/ROCK pathway was dependent on Western Blot and Q-PCR
methods.
Results: The level of endothelial cell (EA.hy926) permeability was increased in LPA
treated group. While compared with the model group, BS-KS treatment signiﬁcantly
attenuated effctcs of LPA on cells’ hyperpermeability responses (P <0.05). Immu-
noﬂuorescence showed that treatment of cells reduced stress ﬁber formation. At the
same time, RhoA activity was inhibited, and P-MLC and ROCK2 expression was
signiﬁcantly downregulated both mRNA and protein levels (P <0.05 or P <0.01.).
Conclusions: BS-KS has a role in protecting endothelial cells and inhibiting LPA-
induced endothelial hyperpermeability response. Which may be achieved byasic and Translational Medicine C27
